These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 7546932)
1. [Gene therapy of glioma using cytokine]. Ikeda H; Yoshida J No To Shinkei; 1995 Sep; 47(9):835-43. PubMed ID: 7546932 [No Abstract] [Full Text] [Related]
2. [Gene therapy for brain tumors: cytokine gene therapy using DNA/liposome (series 3)]. Okada H; Okamoto S; Yoshida J No Shinkei Geka; 1994 Nov; 22(11):999-1004. PubMed ID: 7816184 [No Abstract] [Full Text] [Related]
3. [Gene therapy for brain tumors: antitumor effects of introduction of antisense and tumor suppressor gene (series 2)]. Nitta T No Shinkei Geka; 1994 Oct; 22(10):903-9. PubMed ID: 7969756 [No Abstract] [Full Text] [Related]
4. Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells. Okada H; Villa L; Attanucci J; Erff M; Fellows WK; Lotze MT; Pollack IF; Chambers WH Gene Ther; 2001 Aug; 8(15):1157-66. PubMed ID: 11509946 [TBL] [Abstract][Full Text] [Related]
5. [Approach to human glioma cells using antisense molecules]. Yoshida S; Tanaka R No To Shinkei; 1995 Sep; 47(9):823-8. PubMed ID: 7546930 [No Abstract] [Full Text] [Related]
6. [Biology and gene therapy of glioma]. Sanson M; Hoang-Xuan K Rev Prat; 1996 Feb; 46(4):464-8. PubMed ID: 8729353 [TBL] [Abstract][Full Text] [Related]
7. Potential confounding features in p53 gene therapy of recurrent glioma. Weil RJ J Clin Oncol; 2004 Apr; 22(7):1344-5; author reply 1345. PubMed ID: 15051789 [No Abstract] [Full Text] [Related]
8. [Usefulness of myelin basic protein gene promoter for the gene therapy of malignant glioma]. Miyao Y; Shimizu K; Hayakawa T; Mikoshiba K Tanpakushitsu Kakusan Koso; 1995 Dec; 40(17):2618-23. PubMed ID: 8584710 [No Abstract] [Full Text] [Related]
9. Treatment of intracranial glioma with in situ interferon-gamma and tumor necrosis factor-alpha gene transfer. Ehtesham M; Samoto K; Kabos P; Acosta FL; Gutierrez MA; Black KL; Yu JS Cancer Gene Ther; 2002 Nov; 9(11):925-34. PubMed ID: 12386831 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of combined vaccinia virus-mediated antitumor gene therapy with p53, IL-2, and IL-12 in a glioma model. Chen B; Timiryasova TM; Andres ML; Kajioka EH; Dutta-Roy R; Gridley DS; Fodor I Cancer Gene Ther; 2000 Nov; 7(11):1437-47. PubMed ID: 11129286 [TBL] [Abstract][Full Text] [Related]
14. [Progress in the study of neurosurgery China]. Zhao Y; Lin S Zhonghua Yi Xue Za Zhi; 1998 Dec; 78(12):909-10. PubMed ID: 11038855 [No Abstract] [Full Text] [Related]
15. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138 [TBL] [Abstract][Full Text] [Related]
16. Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector. Rubinchik S; Yu H; Woraratanadharm J; Voelkel-Johnson C; Norris JS; Dong JY Cancer Gene Ther; 2003 Nov; 10(11):814-22. PubMed ID: 14605667 [TBL] [Abstract][Full Text] [Related]
17. Tumor targeted gene therapy with plasmid expressing human tumor necrosis factor alpha in vitro and in vivo. Pastorakova A; Hlubinova K; Bodo J; Libby J; Rychly B; Margison G; Altaner C Neoplasma; 2005; 52(4):344-51. PubMed ID: 16059653 [TBL] [Abstract][Full Text] [Related]
18. [Therapy of malignant brain tumors by using apoptosis]. Kuchino Y No To Shinkei; 1995 Sep; 47(9):829-34. PubMed ID: 7546931 [No Abstract] [Full Text] [Related]
19. New innovations and developments for glioma treatment. Croteau D; Mikkelsen T; Rempel SA; Bogler O; Rosenblum M Clin Neurosurg; 2001; 48():60-81. PubMed ID: 11692657 [No Abstract] [Full Text] [Related]
20. Combination of pGL1-TNF-alpha gene and radiation (proton and gamma-ray) therapy against brain tumor. Gridley DS; Li J; Kajioka EH; Andres ML; Moyers MF; Slater JM Anticancer Res; 2000; 20(6B):4195-203. PubMed ID: 11205248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]